Sleep Disorders, Circadian Rhythm
55
5
6
30
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
5.5%
3 terminated out of 55 trials
90.9%
+4.4% vs benchmark
11%
6 trials in Phase 3/4
10%
3 of 30 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 30 completed trials
Clinical Trials (55)
Effect of Melatonin on Sleep Patterns of Resident Trainees During Night Float Shift
Effects of Delayed School Start Times on Sleep, Mental Health, and Academic Performance Among Norwegian Adolescents
ROOM-LIGHT: Dynamic LED-light as Treatment for Depressed Patients in Inpatient Wards
Improvement of Sleep Disorders in Patients With Alzheimer's Disease After Sunlight Exposure Therapy.
Relieving Pain and Improving Sleep: Evaluating Topical Pain Relief and Sleep Patches
Evaluating the Effects of Tasimelteon vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD)
Adult Sleep Health in the Rural Appalachia and Mississippi Delta Region and Its Relationships With Cardiometabolic Health Disparities.
The Role of Circadian Factors in Regulation of Neuroplasticity in Ischemic Stroke (Interventional)
Biomarkers for Circadian Timing in Healthy Adults
Breath Biomarkers for Sleep Loss and Circadian Timing
WEsleep Trial: Improving Sleep in Hospitalized Patients
Bright Light Intervention to Reduce Students' Stress
Evaluating the Efficacy and Safety of PROSOMNIA Sleep Therapy™ in Patients With Sleep Deprivation and Chronic Insomnia
Sleep Disorders, Chronotype, and Functional Impairment in the Restrictive ADHD Phenotype
A Prospective Study: the Impact of Sleep Disturbances on Immunotherapy in Patients With Lung Cancer
Sleep State in Lung Cancer: A Retrospective Analysis
The Effect of Oral Feeding Model With a Chronobiological Approach in Neonates
Measuring the Effectiveness of Forest Therapy to Alleviate Stress Among International Students
High-frequency tRNS for Sleep Disturbances in Neurocognitive Disorders Due to Vascular Disease
Evaluating the Effects of Tasimelteon Vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD) and the CRY1Δ11 Variant